Current status of robotic bariatric surgery: A systematic review

BMC Surgery (Impact Factor: 1.4). 11/2013; 13(1):53. DOI: 10.1186/1471-2482-13-53
Source: PubMed


Bariatric surgery is an effective treatment to obtain weight loss in severely obese patients. The feasibility and safety of bariatric robotic surgery is the topic of this review.
A search was performed on PubMed, Cochrane Central Register of Controlled Trials, BioMed Central, and Web of Science.
Twenty-two studies were included. Anastomotic leak rate was 8.51% in biliopancreatic diversion. 30-day reoperation rate was 1.14% in Roux-en-Y gastric bypass and 1.16% in sleeve gastrectomy. Major complication rate in Roux-en-Y gastric bypass resulted higher than in sleeve gastrectomy ( 4,26% vs. 1,2%). The mean hospital stay was longer in Roux-en-Y gastric bypass (range 2.6-7.4 days).
The major limitation of our analysis is due to the small number and the low quality of the studies, the small sample size, heterogeneity of the enrolled patients and the lack of data from metabolic and bariatric outcomes. Despite the use of the robot, the majority of these cases are completed with stapled anastomosis. The assumption that robotic surgery is superior in complex cases is not supported by the available present evidence. The major strength of the robotic surgery is strongly facilitating some of the surgical steps (gastro-jejunostomy and jejunojejunostomy anastomosis in the robotic Roux-en-Y gastric bypass or the vertical gastric resection in the robotic sleeve gastrectomy).

Download full-text


Available from: Carlo Boselli, Feb 04, 2014
  • Source
    • "Since the first robotic bariatric procedure, placement of an adjustable gastric band was performed in 1998 (Cadiere et al. 1999) by using the Mona, an early version of the current da Vinci System; almost all bariatric surgical procedures have been performed to varying degrees using the robotic system. Systematic reviews had already established the safety and feasible of the robotic approach in all of them (Gill et al. 2011; Cirocchi et al. 2013). RYGB is considered in many countries the gold standard of surgical treatment of morbid obesity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Robotic surgery is an emerging and promising technology in bariatric surgery. Current studies have confirmed its feasibility and safety with a relatively short learning curve. The advantages for the surgeon are already well established with better ergonomics. The potential benefits to the patient are still being studied. Robotic surgery seems to offer more advantages for complex cases, such as super obesity and revisional surgery.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The surgical community and the medical device industry enjoy a fruitful cooperation for the benefit of patients, but during the last years several high-risk products have led to problems and scandals, thus highlighting the need for reforms in European CE marking requirements. In October 2013, the European Parliament voted on a draft regulation on medical devices that intends to replace the current directives in 2014. This article offers guidance to surgeons on how to select and assess medical devices for clinical use. Examples include artificial sphincters, surgical meshes, as well as single-incision and robot-assisted surgery. It is important that surgeons have a basic understanding of the requirements for CE marking of new medical devices. Because device performance rather than effectiveness is required for European market entry, surgeons (and their patients) are often left with the burden of using potentially harmful devices. In addition, potential problems concerning the safety or effectiveness of approved devices are concealed by the lack of data transparency. Because regulatory reforms were blocked at the European level, many member states will now seek other ways of restricting the use of medical devices with unknown effectiveness. One interesting model in this regard is to link the reimbursement of new medical devices to the conduct of clinical trials. Surgeons should develop a structured multidisciplinary approach to innovation management in their hospitals before using a new high-risk device. The key question is how to strike the right balance between innovation and safety.
    Langenbeck s Archives of Surgery 02/2014; 399(3). DOI:10.1007/s00423-014-1173-y · 2.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Little focus has been placed on improving the efficiency of robotic surgery. The aim of this study is to demonstrate areas of inefficiency between robotic (RSG) and laparoscopic sleeve gastrectomy (LSG) and show that the robot can be effectively integrated into a bariatric surgery practice. Methods: We retrospectively identified 25 consecutive LSG and RSG and compared preoperative (patient enters operating room (OR) to skin incision), operative (incision to skin closure), and postoperative (skin closure to out of OR) times. Analysis of variance comparing RSG versus LSG was performed, and turnover times for consecutive cases were analyzed. Results: The mean preoperative, operative, and postoperative times for LSG versus RSG are 42 +/- 8 versus 46 +/- 1, 88 +/- 19 versus 119 +/- 32, and 13 +/- 7.6 versus 11 +/- 5 minutes respectively. There is a statistically significant difference between LSG and RSG operative times (p < 0.001), but there was no significance between preoperative (p = 0.164) and postoperative (p = 0.395) times. Conclusion: The primary contributor to longer duration of a robotic case is the operative time, not preoperative or postoperative times. RSG with a dedicated robotic team can be efficiently performed so that three consecutive RSG can be completed by 3: 30 p. m. in a day.
    06/2014; 9(2):55-60. DOI:10.1089/bari.2014.0009
Show more